Results 81 to 90 of about 1,154 (140)
Novosti v zdravljenju raka dojk in raka jajčnikov ASCO, Annual Meeting, Chicago, 1.-5. 6. 2012
Ni abstrakta.
Iztok Takač, Andraž Dovnik
doaj
Individual Meaning-Centered Psychotherapy for palliative cancer patients in Lithuania. A case report. [PDF]
Sutkevičiūtė M +2 more
europepmc +1 more source
Zdravljenje metastatskega malignega melanoma z vemurafenibom: klinični primer
In Slovenia, just like everywhere else in the world, we are witnessing an upward trend in the incidence of malignant melanoma of the skin. According to the data from the 2009 Cancer Registry of Slovenia, Slovenia recorded 298 and 415 new cases of ...
Boc, Nina +3 more
core
Karcinom nosnega žrela: pregled uspešnosti zdravljenja na Onkološkem inštitutu
Nasopharyngeal carcinoma is a very rare type of malignant tumor which appears sporadically in the district of Slovenia and most parts of the Western world.
Strojan, Primož, Čarman, Janka
core
Pljučni rak kot poklicna in socialna bolezen
Če izvzamemo jasno povezavo s kajenjem, so drugim dejavnikom, ki so pomembni za preventivo, diagnostiko in zdravljenje pljučnega raka, doslej namenjali malo pozornosti. Predstavljamo raziskavo, ki se je osredotočila na socialni položaj bolnikov.
Matjaž Zwitter +2 more
doaj
Hipodermokliza: varen, udoben, praktičen in cenovno ugoden postopek parenteralne hidracije
In clinical practice, hypodermoclysis was first used in the forties of the earlier century in the treatment of pediatric patients for dehydration. It is a safe, comfortable and low-cost method for replacing an excessive loss of body water as well as for ...
Benedik, Jernej, Jelen-Jurič, Jožica
core
Spremljanje bolnikov z MRSA na Onkološkem inštitutu v Ljubljani
Meticilin rezistenten Staphylococcus aureus (MRSA) je pomemben povzročitelj bolnišničnih okužb. Širi se predvsem prek rok zdravstvenega osebja in bolnikov. Možnosti antibiotičnega zdravljenja so omejene. Najpogosteje uporabljamo glikopeptidne antibiotike,
Milena Kerin-Povšič
doaj
Epithelial ovarian cancer is known to be one of the most sensitive to systemic treatment with chemotherapy. Objective response to treatment was achieved in more than 80% of patients.
Škof, Erik, Cerar, Olga
core

